COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 74 filers reported holding COMPASS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $124,679 | -67.0% | 63,289 | -46.8% | 0.00% | – |
Q2 2023 | $378,089 | -27.8% | 118,896 | -25.7% | 0.00% | – |
Q1 2023 | $523,409 | +61.3% | 160,064 | +148.2% | 0.00% | – |
Q4 2022 | $324,425 | +1522.1% | 64,498 | +627.0% | 0.00% | – |
Q3 2022 | $20,000 | +900.0% | 8,872 | +1347.3% | 0.00% | – |
Q2 2022 | $2,000 | -94.6% | 613 | -97.7% | 0.00% | – |
Q1 2022 | $37,000 | -33.9% | 26,977 | +54.4% | 0.00% | – |
Q4 2021 | $56,000 | – | 17,473 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 1,246,977 | $2,456,545 | 3.92% |
CHI Advisors LLC | 2,829,712 | $5,574,532 | 2.21% |
Ally Bridge Group (NY) LLC | 914,630 | $1,801,821 | 2.12% |
Monashee Investment Management LLC | 1,226,142 | $2,415,500 | 1.01% |
Orbimed Advisors | 22,362,850 | $44,054,815 | 0.94% |
Vivo Capital, LLC | 3,556,023 | $7,005,365 | 0.77% |
CAXTON CORP | 86,773 | $170,942 | 0.65% |
Prosight Management, LP | 935,157 | $1,842,259 | 0.58% |
BRAIDWELL LP | 5,954,273 | $11,729,918 | 0.37% |
Rock Springs Capital Management LP | 5,513,788 | $10,862,162 | 0.29% |